Tag Archives: CTRV

Analyst Explains Why They Downgraded Their Rating on ContraVir Pharmaceuticals Inc (CTRV)

Maxim Group analyst Jason McCarthy downgraded ContraVir Pharmaceuticals Inc (CTRV – Research Report) to Hold today. The company’s shares closed yesterday at $0.28, close to its 52-week low of $0.21. McCarthy observed: “ContraVir filed its 10-K on 3/14 for YE18,

Analyst Explains Why They Upgraded Their Buy Rating on ContraVir Pharmaceuticals Inc

In a report released today, Jason McCarthy from Maxim Group upgraded ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) to Buy, with a price target of $3. The company’s shares closed yesterday at $1.18, close to its 52-week low of $1.15. McCarthy commented:

ContraVir Pharmaceuticals Inc Gets a Hold Rating from Maxim Group

Maxim Group analyst Jason McCarthy maintained a Hold rating on ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) today. The company’s shares opened today at $1.65, close to its 52-week low of $1.30. McCarthy observed: “Contravir announced that IND for CRV-431 (cyclophilin inhibitor)

Maxim Group Releases a Hold Rating on ContraVir Pharmaceuticals Inc

In a report released today, Jason McCarthy from Maxim Group assigned a Hold rating to ContraVir Pharmaceuticals Inc (NASDAQ: CTRV). The company’s shares opened today at $1.92, close to its 52-week low of $1.64. McCarthy noted: “Summary Contravir announced new

Maxim Group Thinks ContraVir Pharmaceuticals Inc’s Stock is Going to Recover

Maxim Group analyst Jason Kolbert assigned a Buy rating to ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) today and set a price target of $4. The company’s shares opened today at $0.56, close to its 52-week low of $0.45. According to TipRanks.com,

Noble Financial Releases a Buy Rating on ContraVir Pharmaceuticals Inc

In a report released yesterday, Mark Jordan from Noble Financial reiterated a Buy rating on ContraVir Pharmaceuticals Inc (NASDAQ: CTRV). The company’s shares closed yesterday at $1.50. According to TipRanks.com, Jordan is a 1-star analyst with an average return of